Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Thomas

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"Nicholas J Thomas, Nathaniel J Myall, Fangdi Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With RadiationNicholas J Thomas, Nathaniel J Myall, Fangdi Sun, et al.
Diabetes Care|November 13, 2020
Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated <i>ABCC8</i> Permanent Neonatal DiabetesPamela Bowman, Frances Mathews, Fabrizio Barbetti, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2018
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort studyPamela Bowman, Åsta Sulen, Fabrizio Barbetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Cell|August 22, 2020
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA SequencingAshley Maynard, Caroline E McCoach, Julia K Rotow, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"Nicholas J Thomas, Nathaniel J Myall, Fangdi Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With RadiationNicholas J Thomas, Nathaniel J Myall, Fangdi Sun, et al.
Diabetes Care|November 13, 2020
Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated <i>ABCC8</i> Permanent Neonatal DiabetesPamela Bowman, Frances Mathews, Fabrizio Barbetti, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2018
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort studyPamela Bowman, Åsta Sulen, Fabrizio Barbetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Cell|August 22, 2020
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA SequencingAshley Maynard, Caroline E McCoach, Julia K Rotow, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 5